Beginning in 2022, businesses will have to amortize R&D expenses instead of being able to deduct them in the year in which they occurred. Today, we speak with Sharon Heck, the corporate vice president, finance and chief tax officer at Intel, to see how this new law will impact corporate taxpayers—and why innovators are lobbying to repeal it.

Preparing the corporate income tax provision is one of the most complicated jobs in the tax department. Committing to these best practices—all culled from this podcast—promise to make it easier in 2022.

Here, a few best practices for 2022 that every transfer pricing professional should embrace.

The IRS’s new guidance offers taxpayers additional compliance burdens—and it goes into effect on January 10, 2022. (That’s right—next week!) What does it mean for taxpayers? CrossBorder Solutions R&D tax credit expert Lydia Clowney spells it out right here.

CrossBorder Solutions' Manager of R&D Tax Credit Lydia Clowney takes a closer look at R&D innovation zones in New Jersey and Nevada and explains the impact of these policies on R&D activities in the states they're designed to serve.

Stock based compensation is a way of paying company members with equity in the business, which is great for companies and employees. From a transfer pricing perspective, however, it can cause problems. Here, David Chamberlain of California Polytechnic State University-San Luis Obispo explains some of the issues that can arise and what multinational companies can do about them.

Granted, the latest round of U.S. tax reform is still in the proposal stages, but if Congress passes new tax laws in 2022, it will have an immediate impact on companies' quarterly and annual financial statements. What could change? What adjustments will tax managers have to make as a result? CrossBorder Solutions’ Howard Telson is unpacking it all right here.